LH
Laboratory Corporation of America Holdings
Price:  
197.09 
USD
Volume:  
677,753.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LH EV/EBITDA

-16.5%
Upside

As of 2024-05-24, the EV/EBITDA ratio of Laboratory Corporation of America Holdings (LH) is 12.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LH's latest enterprise value is 21,686.02 mil USD. LH's TTM EBITDA according to its financial statements is 1,742.90 mil USD. Dividing these 2 quantities gives us the above LH EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.2x - 12.4x 11.9x
Forward P/E multiples 11.3x - 16.5x 13.8x
Fair Price 105.86 - 196.21 164.60
Upside -46.3% - -0.4% -16.5%
197.09 USD
Stock Price
164.60 USD
Fair Price

LH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 12.44
2024-05-22 12.64
2024-05-21 12.84
2024-05-20 12.91
2024-05-17 13.10
2024-05-16 13.22
2024-05-15 13.22
2024-05-14 13.12
2024-05-13 13.08
2024-05-10 12.95
2024-05-09 12.88
2024-05-08 12.66
2024-05-07 12.66
2024-05-06 12.63
2024-05-03 12.65
2024-05-02 12.60
2024-05-01 12.65
2024-04-30 12.65
2024-04-29 12.78
2024-04-26 12.51
2024-04-25 12.50
2024-04-24 12.97
2024-04-23 12.97
2024-04-22 12.73
2024-04-19 12.65
2024-04-18 12.56
2024-04-17 12.58
2024-04-16 12.68
2024-04-15 12.74
2024-04-12 12.86
2024-04-11 12.90
2024-04-10 12.93
2024-04-09 13.07
2024-04-08 13.07
2024-04-05 13.13
2024-04-04 13.13
2024-04-03 13.18
2024-04-02 13.16
2024-04-01 13.37
2024-03-28 13.48
2024-03-27 13.38
2024-03-26 13.24
2024-03-25 13.25
2024-03-22 13.22
2024-03-21 13.13
2024-03-20 13.04
2024-03-19 13.11
2024-03-18 13.04
2024-03-15 13.03
2024-03-14 13.02